Nutrition Physiology Company, LLC (NPC) today announced that it has entered into a definitive agreement to be acquired by Chr. Hansen.

NPC is committed to enhancing the health and productivity of animals with its products BOVAMINE®, BOVAMINE DEFEND®, BOVAMINE® DAIRY and POULTRIMAX® and has built a reputation as the trusted partner for developing innovative probiotic microbial solution products for the cattle and poultry industries. Chr. Hansen is a leading developer and manufacturer of microbial solutions for animal health globally.

“Over the last five years, NPC has delivered excellent value to existing customers, expanded to serve new types of livestock customers, and introduced new product formulations. Our employees have been critical to our success and effectively servicing our customers,” said Tony Arnold, Chairman and CEO, NPC. “The sale of NPC to Chr. Hansen will provide access to a broader array of resources and a global footprint, which will enable further expansion and customer service.”

“One of the ambitions in our Nature’s No. 1 strategy is to expand our current business within microbial solutions for animal health. Through this acquisition we create a stronger platform in probiotics that help farmers improve productivity and health through natural means. I am therefore very pleased to announce the acquisition of NPC and I look forward to welcoming its 52 employees to Chr. Hansen. Together we will capture future growth within microbial solutions to the livestock industry,” says Cees de Jong, CEO, Chr. Hansen.

There is a strong strategic fit between NPC products and Chr. Hansen’s animal health business, providing access to new markets, manufacturing and supply chain efficiencies and product innovation, which will further enhance the service offering to customers in the livestock industry through a broader range of high-quality products.

The acquisition is subject to customary closing conditions, including applicable regulatory approvals, and is expected to close during the first quarter of 2016.